-+ 0.00%
-+ 0.00%
-+ 0.00%

PERSPECTIVE THERAPEUTICS PRESENTS ENCOURAGING INCREMENTAL DATA AND ANALYSES FROM PHASE 1/2A TRIAL OF [212PB]BAMZIREOTIDE NAVOXETAN (VMT-Α-NET) IN ADVANCED SSTR2 EXPRESSING NETS

Reuters·11/06/2026 01:10:00

Please log in to view news